FIELD: medicine; ophthalmology.
SUBSTANCE: invention can be used to predict the clinical course of stage 2 of active retinopathy of prematurity according to ultrasonic biomicroscopy (UBM). That is ensured by ultrasonic biomicroscopy. On the obtained images of the peripheral parts of the subscleral space, the retina and the vitreoretinal interface in the peripheral parts of the retina are assessed in detail. Length and height of the demarcation shaft are estimated. Favorable clinical course of 2nd stage of active retinopathy is predicted in the presence of a demarcation shaft in the form of a section of retinal prominence into the vitreous body cavity with height of 0.27–0.39 mm, localized in temporal, upper or lower segments with length of 4–8 hour meridians (HM) without signs of involvement of structures of vitreous body in pathological process. Unfavorable clinical course of 2nd stage of active retinopathy with a high risk of the disease progression to 3rd stage is predicted by the presence of at least one of the following signs according to UBM: in the presence of a demarcation shaft in the form of a zone of prominence of the retina into the cavity of the vitreous body with height of 0.42–0.62 mm, having a triangular shape, with length of 6–12 HM; demarcation shaft in the nasal segment, meridians of 2–4 hours for the right eye and 8–10 hours for the left eye, regardless of its height; in the presence of point hyperechoic inclusions on the surface of the retina on the demarcation shaft without signs of changes in the structures of the vitreous body.
EFFECT: invention provides the reliable prediction of the clinical course of the given pathology on the basis of structural disturbances in the peripheral fundus according to UBM data for determining the early management of the patients.
1 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINATION OF INDICATIONS TO PRIMARY VITREORETINAL SURGERY AT POSTERIOR AGGRESSIVE RETINOPATHY OF PREMATURE NEWBORNS | 2016 |
|
RU2625298C1 |
METHOD FOR PREDICTING THE TYPE OF COURSE OF STAGES 1-2 OF ACTIVE RETINOPATHY OF PREMATURITY ACCORDING TO ULTRASOUND BIOMICROSCOPY DATA | 2023 |
|
RU2804675C1 |
METHOD FOR SELECTING AN APPROACH FOR TREATING AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY AT DISEASE ONSET | 2018 |
|
RU2677212C1 |
METHOD FOR SELECTING THERAPEUTIC APPROACH TO UNFAVOURABLE CLINICAL COURSE OF STAGE 3 OF ACTIVE RETINOPATHY OF PREMATURITY | 2023 |
|
RU2822591C1 |
METHOD FOR PREDICTING I-III STAGES OF ACTIVE RETINOPATHY OF RETINOPATHY OF PREMATURITY ON THE BASIS OF DATA OF FLUORESCENCE ANGIOGRAPHY | 2017 |
|
RU2666268C1 |
A METHOD FOR DETERMINING INDICATIONS FOR PRIMARY VITRECTOMY WITH AN UNFAVORABLE TYPE OF COURSE OF STAGE 3 ACTIVE RETINOPATHY OF PREMATURITY | 2022 |
|
RU2787146C1 |
METHOD FOR PREDICTION OF REGRESSION OF STAGE II AND III RETINOPATHY OF PREMATURITY FOLLOWING LASER COAGULATION OF RETINA | 2013 |
|
RU2532497C1 |
PREDICTION METHOD OF COURSE OF ACTIVE STAGES OF MISBORN RETINOPATHY | 2007 |
|
RU2340314C1 |
METHOD OF DETERMINING INDICATIONS FOR EARLY SURGICAL TREATMENT OF POSTERIOR AGGRESSIVE RETINOPATHY IN PREMATURELY BORN BABIES | 2009 |
|
RU2395254C1 |
METHOD FOR DIAGNOSING PREVALENCE OF NEOPLASTIC PROCESS IN PRE-EQUATORIAL ZONE OF FUNDUS | 2023 |
|
RU2807528C1 |
Authors
Dates
2024-07-09—Published
2023-09-18—Filed